![Frederick Callori](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Frederick Callori
Directeur/Membre du Conseil chez
LEONABIO, INC.
Fortune : - $ au 31/07/2026
Profil
Frederick P.
Callori is Chairman & Chief Executive Officer at Neurosterix SA since 2024.
Holds the position of Independent Director at LeonaBio, Inc. starting 2026.
Serves as Director at CereVasc, Inc., Quellis Biosciences LLC, Zucara Therapeutics, Inc., and Polycore Therapeutics, Inc. Managing Director & Venture at Perceptive Advisors (Private Equity) since 2018.
Former Independent Director at Astria Therapeutics, Inc. from 2021 to 2026 and at Landos Biopharma, Inc. from 2021 to 2024.
Partner at Choate, Hall & Stewart LLP from 1998 to 2017.
Executive Vice President & Senior Partner at Xontogeny LLC from 2023 to 2024.
Educated at State University of New York at Binghamton (undergraduate) and Boston University School of Law (graduate).
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEONABIO, INC. -.--% | 23/06/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Postes actifs de Frederick Callori
| Sociétés | Poste | Début |
|---|---|---|
| LEONABIO, INC. | Directeur/Membre du Conseil | 05/05/2026 |
CereVasc, Inc.
 CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Directeur/Membre du Conseil | - |
Zucara Therapeutics, Inc.
 Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Directeur/Membre du Conseil | - |
Quellis Biosciences LLC
 Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Directeur/Membre du Conseil | - |
Polycore Therapeutics, Inc.
 Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Directeur/Membre du Conseil | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Private Equity Investor | 01/01/2018 |
Anciens postes connus de Frederick Callori
| Sociétés | Poste | Fin |
|---|---|---|
| ASTRIA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 23/01/2026 |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Corporate Officer/Principal | 01/12/2024 |
| LANDOS BIOPHARMA, INC. | Directeur/Membre du Conseil | 23/05/2024 |
| ░░░░░░░ ░░░░ ░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Frederick Callori
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Choate, Hall & Stewart LLP
 Choate, Hall & Stewart LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Astria Therapeutics, Inc.
 Astria Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel therapeutics for rare and niche allergic & immunological diseases | Health Technology |
LeonaBio, Inc.
 LeonaBio, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
State University of New York at Binghamton
 State University of New York at Binghamton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
 Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CereVasc, Inc.
CereVasc, Inc. Medical SpecialtiesHealth Technology Develops medical devices for neurological diseases | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors invests in public and private middle market companies located across the globe. The firm focuses across a broad range of sectors and industries. It provides financing in the form of equity and debt for seed, early, later stage and growth transactions with an investment size of USD 10 – 300 million. The firm acts as lead and co-lead investor. It also takes a seat on a board of directors. | Finance |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Operates biotech aggregator company | Health Technology |
Quellis Biosciences LLC
Quellis Biosciences LLC Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company that develops antibody therapies | Health Technology |
Zucara Therapeutics, Inc.
Zucara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug therapy for hypoglycemia in type 1 diabetes people | Health Technology |
Polycore Therapeutics, Inc.
Polycore Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic treatment for central nervous system diseases | Health Technology |
